United States · 
Who invested in Affect Therapeutics?
Affect Therapeutics's investors include Y Combinator, Samsung Next, Kapor Capital, AlleyCorp and Artis Ventures (AV).
United States · Series A startup
Who invested in Affect Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $16MJul 2023
- Investors
- 5
The rounds
- Jul 2023Series A$16M
Source recordedSEC filing: $18M sold, first sale Dec 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Affect Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Affect Therapeutics
How much has Affect Therapeutics raised?
Affect Therapeutics has raised $16M across 1 round since 2023.
When did Affect Therapeutics last raise?
Affect Therapeutics's most recent round was a Series A of $16M in Jul 2023.
What was Affect Therapeutics's biggest round?
Its most recent round, $16M in Jul 2023, is also its largest on record.
Who backed Affect Therapeutics first?
Affect Therapeutics's first round on record, in Jul 2023, was backed by Y Combinator, Samsung Next and Kapor Capital and 2 others.
What stage is Affect Therapeutics at?
Affect Therapeutics's latest named round is a Series A, in Jul 2023.
Where is Affect Therapeutics based?
Affect Therapeutics is based in the United States.
Companies like Affect Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.